Lantus
Cost of diabetes treatment soars in England
August 13, 2014Medical Communications, Research and Development, Sales and Marketing Lantus, NHS, Sanofi, diabetes
The NHS spent more than £2.2 million on average every day over the last financial year on diabetes medicines, according …
Sanofi files Lilly lawsuit
February 3, 2014Sales and Marketing FDA, Lantus, Sanofi, lilly
A row which has been brewing between Sanofi and Eli Lilly & Company has now erupted with the French manufacturer …
New insulin scores for Sanofi
December 5, 2013Research and Development, Sales and Marketing Lantus, Sanofi, diabetes, u300
Sanofi has been cheered after late-stage results from its investigational insulin U300 showed that the product may have advantages over …
Pfizer pulls out of $350 million insulin pact
March 14, 2012Research and Development, Sales and Marketing Biocon, Humalog, Lantus, NovoLog, Pfizer
Pfizer has walked away from a research deal with India’s biggest biotech firm Biocon. Both companies were working on a …
No cancer link with Lantus, says Sanofi
December 7, 2011Sales and Marketing Cancer, Lantus, Sanofi, diabetes, insulin, safety
Sanofi has presented a new meta-analysis which suggests its insulin blockbuster Lantus does not raise the risk of cancer. A …
Sanofi picks two agencies for UK diabetes account
February 25, 2011Medical Communications Lantus, Sanofi-Aventis, Tudor Reilly, diabetes, medical communications account win, red health
Healthcare PR agencies Tudor Reilly and Red Health have jointly won the Sanofi-Aventis UK diabetes account after a five-way pitch. …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
